Furazolidone structure
|
Common Name | Furazolidone | ||
|---|---|---|---|---|
| CAS Number | 67-45-8 | Molecular Weight | 225.158 | |
| Density | 1.7±0.1 g/cm3 | Boiling Point | 353.4±52.0 °C at 760 mmHg | |
| Molecular Formula | C8H7N3O5 | Melting Point | 254-256ºC (dec.) | |
| MSDS | Chinese USA | Flash Point | 167.5±30.7 °C | |
| Symbol |
GHS08 |
Signal Word | Warning | |
Use of FurazolidoneFurazolidone is a nitrofuran derivative with antiprotozoal and antibacterial activity, inhibits AML1-ETO transformed cells with IC50 value of 12.7 μM.Target: Antibacterial Furazolidone is a novel therapeutic strategy in AML patients. Furazolidone can Inhibit the bone-marrow transformation mediated by a series of leukemia fusion proteins. Furazolidone significantly inhibits proliferation of AML cell lines. Furazolidone induces apoptosis of the AML leukemic cells treatment with Furazolidone induces differentiation of AML cell lines. |
| Name | furazolidone |
|---|---|
| Synonym | More Synonyms |
| Description | Furazolidone is a nitrofuran derivative with antiprotozoal and antibacterial activity, inhibits AML1-ETO transformed cells with IC50 value of 12.7 μM.Target: Antibacterial Furazolidone is a novel therapeutic strategy in AML patients. Furazolidone can Inhibit the bone-marrow transformation mediated by a series of leukemia fusion proteins. Furazolidone significantly inhibits proliferation of AML cell lines. Furazolidone induces apoptosis of the AML leukemic cells treatment with Furazolidone induces differentiation of AML cell lines. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.7±0.1 g/cm3 |
|---|---|
| Boiling Point | 353.4±52.0 °C at 760 mmHg |
| Melting Point | 254-256ºC (dec.) |
| Molecular Formula | C8H7N3O5 |
| Molecular Weight | 225.158 |
| Flash Point | 167.5±30.7 °C |
| Exact Mass | 225.038574 |
| PSA | 100.86000 |
| LogP | -0.49 |
| Vapour Pressure | 0.0±0.8 mmHg at 25°C |
| Index of Refraction | 1.670 |
| InChIKey | PLHJDBGFXBMTGZ-UITAMQMPSA-N |
| SMILES | O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1 |
| Storage condition | 0-6°C |
| Water Solubility | formic acid: soluble50mg/mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS08 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H361 |
| Precautionary Statements | P281 |
| Personal Protective Equipment | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | Xn:Harmful |
| Risk Phrases | R62 |
| Safety Phrases | S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | RQ3675000 |
| HS Code | 2934992000 |
|
~%
Furazolidone CAS#:67-45-8 |
| Literature: Journal of the American Chemical Society, , vol. 77, p. 2282 |
|
~%
Furazolidone CAS#:67-45-8 |
| Literature: Journal of the American Chemical Society, , vol. 77, p. 2282 |
|
~%
Furazolidone CAS#:67-45-8 |
| Literature: Journal of the American Chemical Society, , vol. 77, p. 2277,2280, 2281 |
|
~%
Furazolidone CAS#:67-45-8 |
| Literature: Journal of the American Chemical Society, , vol. 77, p. 2277,2280, 2281 |
|
~%
Furazolidone CAS#:67-45-8 |
| Literature: Journal of the American Chemical Society, , vol. 77, p. 2277,2280, 2281 |
|
~%
Furazolidone CAS#:67-45-8 |
| Literature: Industrial and Engineering Chemistry, , vol. 47, p. 358,359 Przemysl Chemiczny, , vol. 36, p. 400 Chem.Abstr., , p. 3140 |
|
~%
Furazolidone CAS#:67-45-8 |
| Literature: US2898335 , ; |
|
~%
Furazolidone CAS#:67-45-8 |
| Literature: US2742462 , ; |
| Precursor 10 | |
|---|---|
| DownStream 3 | |
| HS Code | 2934992000 |
|---|
|
Beneficial effects of intramyocardial mesenchymal stem cells and VEGF165 plasmid injection in rats with furazolidone induced dilated cardiomyopathy.
J. Cell. Mol. Med. 19 , 1868-76, (2015) To explore the impact of myocardial injection of mesenchymal stem cells (MSCs) and specific recombinant human VEGF165 (hVEGF165 ) plasmid on collagen remodelling in rats with furazolidone induced dila... |
|
|
Novel UV-spectrophotometric method for quantitative estimation of furazolidone using mixed hydrotropic agent.
Pak. J. Pharm. Sci. 26(1) , 159-62, (2013) A novel, eco friendly, accurate, sensitive, economic and safe spectrophotometric method was developed by application of mixed hydrotropy using 2 M sodium acetate, 8 M urea, 2 M niacinamide and 2 M sod... |
|
|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Chem. Res. Toxicol. 23 , 171-83, (2010) Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental... |
|
Name: Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression
Source: NCGC
External Id: SNCA-p-activity-luciferase
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify ago...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
Name: Cytochrome P450 Family 1 Subfamily A Member 2 (CYP1A2) small molecule antagonists: lu...
Source: 824
External Id: CYP273
|
|
Name: Increase the activity of the Burkholderia fixLJ 2-component system
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: Burkholderia multivorans
External Id: HMS1625
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify pos...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_PAM_FLUO8_1536_1X%ACT PRUN
|
|
Name: qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity
Source: NCGC
External Id: HERG01
|
|
Name: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen
Source: NCGC
Target: N/A
External Id: SMAD3201
|
|
Name: uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay
Source: Burnham Center for Chemical Genomics
Target: cystic fibrosis transmembrane conductance regulator [Homo sapiens]
External Id: SBCCG-A764-CF-PAF-Primary-Assay
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify ant...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_ANT_FLUO8_1536_1X%INH PRUN
|
| Furall |
| Bifuron |
| MFCD00010550 |
| 3-[(5-Nitrofurfurylidene)amino]-2-oxazolidinone |
| 3-{(E)-[(5-Nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one |
| 3-[(5-Nitrofurfurylidene)amino]-2-oxazolidone |
| Furidon |
| Furazolidone |
| 3-{[(E)-(5-Nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one |
| Neftin |
| nf-180 |
| Furazon |
| Furazol |
| Furaxon |
| Furox |
| 3-[[(5-Nitro-2-furanyl)methylene]amino]-2-oxazolidinone |
| EINECS 200-653-3 |